Drug intelligence / Profile preview

modified Ma Xing Shi Gan Decoction

Development stage
Unknown
Lead developer
Cuiling Feng
Modality
Small Molecules
Administration
Oral
01

Overview

Modified Ma Xing Shi Gan Decoction is a traditional Chinese medicine (TCM) polyherbal formulation being evaluated for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD). This specific modification, studied by investigator Cuiling Feng, is based on the classic Ma Xing Shi Gan Decoction—originally consisting of *Ephedra sinica*, *Prunus armeniaca*, *Gypsum fibrosum*, and *Glycyrrhiza uralensis*—and is tailored to address the 'Lung-Large Intestine Mutual Interior-Exterior Relationship' theory. The formula is intended to clear lung heat, resolve phlegm, and relieve dyspnea by modulating systemic and local inflammation. In clinical trials, it is administered as an oral decoction in combination with standard Western medical care (such as bronchodilators and antibiotics), with the primary goal of reducing hospital stay duration and improving clinical symptoms like cough, phlegm, and breathlessness.

Other names
Modified Maxing Shigan DecoctionMXSGDModified Ma-Xing-Shi-Gan-Tang
02

Targets

TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)ADRB2 (β2)

Beyond the preview

Go deeper on modified Ma Xing Shi Gan Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on modified Ma Xing Shi Gan Decoction.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call